# Reviewer A — Pair 2 (AIDs 624326 / 624327): preliminary assessment

**Recorded:** 2026-10-14  
**Review sequence:** Pair 2/43, frozen CSV row 1  
**Pair key:** `PUBCHEM::NP_004095::IC50::624326::624327`  
**Status:** AUTHOR-COORDINATED, AI-ASSISTED PRELIMINARY HUMAN REVIEW. Not blinded, not verified external expert validation, not reconciled consensus.  
**Reviewer identity/credentials:** Reviewer A; qualification, independence, conflicts, and signed declaration remain to be verified securely outside the repository.

## Reviewer A's submitted selections (preserved, not silently changed)

- Measurement data reuse: `UNRESOLVED`
- Physical experimental execution: `UNRESOLVED`
- Discovery-program lineage: `SHARED_PROGRAM`

## Reviewer-provided source rationale (faithfully summarized)

Original PubChem AIDs [624326](https://pubchem.ncbi.nlm.nih.gov/bioassay/624326) and [624327](https://pubchem.ncbi.nlm.nih.gov/bioassay/624327) identify the Sanford-Burnham Center for Chemical Genomics, grant `1R03MH095532-01`, and assay provider Jeffrey Smith. AID 624326 describes kinetic dose-response FAS-TE inhibition using fluorogenic OMFH; the procedure records 480/540 nm fluorescence at 10-minute intervals and calculates reaction slopes. AID 624327 describes an endpoint-fluorescence dose-response confirmation of uHTS hits. Both appear as separate confirmation assays in [NIH Molecular Libraries FAS-TE Table 2](https://www.ncbi.nlm.nih.gov/books/NBK189923/table/ml356.t2/), supporting a common probe-development project. Their distinct formats do not prove copied data or physical run independence. The original assay result tables and possible replicate/plate/run identifiers have not been reviewed sufficiently to resolve these dimensions. The reviewer reports live-page access barriers and relies on the NCBI indexed assay descriptions and NIH report.

## Independent documentary quality check by the assistant (not human validation)

Original official PubChem description JSON files from successful GitHub R1 source-recovery Run #1 were checked. Key locators:

- Both `description[0:5]`: center, network, grant and provider, including `description[3]` and `description[4]`.
- Both `description[8]`: confirmation of hits from primary assay `AID 602261`.
- AID `624326`, `protocol[39]`: repeated excitation 480 nm/emission 540 nm readings, reaction slope from T0 to minute 50.
- AID `624327`, `protocol[40]`: single fluorescence read on EnVision at excitation 480 nm/emission 540 nm.
- **Source nuance:** AID 624326 `protocol[1]` calls its readout "endpoint" despite its title and specific `protocol[39]` procedure describing kinetic monitoring. Treat the detailed method as supporting a kinetic format; preserve the inconsistency in audit notes, do not conceal it.
- Both AID description `xref` fields link AIDs 602261 and 602265, the common primary and summary assays, rather than directly cross-referencing one another.
- Frozen registry contained **1003 shared exact CIDs** for this selected pair. Compound overlap cannot distinguish reuse from independent measurements.
- [NIH Molecular Libraries Table 2](https://www.ncbi.nlm.nih.gov/books/NBK189923/table/ml356.t2/) lists 624326 kinetic and 624327 endpoint assay records in a single FAS-TE project.

**QA outcome:** The three selected classifications are supported at their stated evidence level. Program-level shared linkage is supported; data reuse and physical execution remain unresolved. This is not evidence that both assay records are a copied measurement, nor an independently verified pair classification.

## Additional evidence needed for rigorous sign-off

1. Review both PubChem result tables at SID/CID level, per-dose observations and fitted IC50; check whether raw kinetic and endpoint values are independently recorded or derived from the same plate (where available).
2. Seek exact measurement-run identifiers, experimental dates, plate layouts, and replicate metadata from source provider or associated published supplementary documentation if not deposited.
3. Obtain reviewer qualifications/conflict declaration; obtain a separate qualified human review independently of this chat; reconcile real disagreements.
4. Freeze only a separately versioned consensus after both actual human reviews. Do not modify the historical P1_10D file.

**Current recorded status:** Reviewer A selections captured; human-verification governance incomplete; no external/blinded expert consensus; original 0/43 counts unchanged.
